Source: Annual Congress 2005 - Diffuse parenchymal lung diseases: experimental animal studies and case reports
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Gunes, A. Gulcu, M. Soyturk, U. Eritmen, A. Onen, A. Kargi, A. H. Cimrin (Izmir, Turkey). A case of Langerhans cell histiocytosis with sclerosing cholangitis. Eur Respir J 2005; 26: Suppl. 49, 625

Member's Comments

No comment yet.

Related content which might interest you: Pneumothorax in patients with Langerhans cell histiocytosis Source: International Congress 2017 – The acute patient: the clinical point-of-view Year: 2017 How I manage pulmonary Langerhans cell histiocytosis Source: Eur Respir Rev, 26 (145) 170070; 10.1183/16000617.0070-2017 Year: 2017 Pulmonary Langerhans cell histiocytosis Source: Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases Year: 2008 Pulmonary Langerhans‘ cell histiocytosis Source: Eur Respir J 2006; 28: Suppl. 50, 826s Year: 2006 Langerhans cell histiocytosis: is it an ILD? Source: Virtual Congress 2021 – Interstitial lung diseases Year: 2021 Pneumothorax in pulmonary langerhans cell histiocytosis (PLCH) Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Pulmonary Langerhans' cell histiocytosis Source: Respipedia Article Year: 2016 A rare case of multiple sclerosing hemangiomas of the lung Source: Eur Respir J 2006; 28: Suppl. 50, 79s Year: 2006 Chemotherapy in patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018 Pulmonary Langerhans' cell histiocytosis Source: Eur Respir Mon; 2009: 46: 155–175 Year: 2009 Paediatric pulmonary Langerhans cell histiocytosis Source: Breathe, 16 (2) 200003; 10.1183/20734735.0003-2020 Year: 2020 Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Pulmonary Langerhans cell histiocytosis associated with Hodgkin's lymphoma Source: Eur Respir Rev 2009; 19: 86-88 Year: 2010 Effect of cladribine therapy on lung cysts in pulmonary Langerhans cell histiocytosis Source: ERJ Open Res, 4 (1) 00089-2017; 10.1183/23120541.00089-2017 Year: 2018 Recurrent NRAS mutations in pulmonary Langerhans cell histiocytosis Source: Eur Respir J 2016; 47:1785-1796 Year: 2016 Lung transplantation for pulmonary Langerhans‘ cell histiocytosis Source: Eur Respir J 2005; 26: Suppl. 49, 635s Year: 2005 Clinical study of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Sclerosing hemangioma of the lung Source: Eur Respir J 2006; 28: Suppl. 50, 79s Year: 2006 Cladribine as a second line treatment in a child with isolated pulmonary Langerhans cell histiocytosis – case report Source: International Congress 2018 – Orphan diseases in children Year: 2018